NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in NextCure, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +4 vs. Q4 2023
- Shares held
- 16.1M
- +2.80M (+21.0%) vs. Q4 2023
- Total value
- $36.0M
- +$20.7M (+135.7%) vs. Q4 2023
- New holders
- 6
- 9 more added
- Sold out
- 2
- 12 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NXTC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 30 | $2.78M |
| Q1 2026 | 26 | $23.0M |
| Q4 2025 | 24 | $26.9M |
| Q3 2025 | 17 | $5.03M |
| Q2 2025 | 30 | $5.65M |
| Q1 2025 | 38 | $7.38M |
| Q4 2024 | 46 | $13.1M |
| Q3 2024 | 44 | $21.7M |
| Q2 2024 | 49 | $25.5M |
| Q1 2024 | 47 | $36.0M |
| Q4 2023 | 43 | $15.3M |
| Q3 2023 | 41 | $16.6M |
| Q2 2023 | 43 | $24.0M |
| Q1 2023 | 44 | $19.6M |
| Q4 2022 | 45 | $18.9M |
| Q3 2022 | 52 | $41.8M |
| Q2 2022 | 51 | $67.9M |
| Q1 2022 | 59 | $64.3M |
| Q4 2021 | 71 | $86.2M |
| Q3 2021 | 71 | $99.5M |
| Q2 2021 | 78 | $124.2M |
| Q1 2021 | 92 | $179.8M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding NextCure, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 17 | $0 | 0.00% | −248−93.6% | Reduced |
| Qube Research & Technologies Ltd | 48 | $107 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 385 | $859 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 703 | $1.57K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 803 | $1.79K | 0.00% | −702−46.6% | Reduced |
| Wells Fargo & Company | 2,157 | $4.81K | 0.00% | +2,002+1,291.6% | Added |
| Tower Research Capital LLC (TRC) | 2,274 | $5.07K | 0.00% | −5,817−71.9% | Reduced |
| Bank of America Corp | 2,726 | $6.08K | 0.00% | +2,701+10,804.0% | Added |
| Charles Schwab Investment Management Inc | 10,000 | $22.3K | 0.00% | 00.0% | Unchanged |
| HarbourVest Partners LLC | 10,044 | $22.4K | 0.01% | 00.0% | Unchanged |
| UBS Group AG | 10,813 | $24.1K | 0.00% | +4,546+72.5% | Added |
| HSBC Holdings PLC | 17,363 | $38.7K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 19,680 | $43.9K | 0.01% | +2,452+14.2% | Added |
| LPL Financial LLC | 27,000 | $60.2K | 0.00% | +11,968+79.6% | Added |
| Northern Trust Corp | 33,746 | $75.3K | 0.00% | +742+2.2% | Added |
| Ieq Capital, LLC | 37,342 | $83.3K | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 43,014 | $95.9K | 0.03% | −17,400−28.8% | Reduced |
| State Street Corp | 57,092 | $127.3K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 57,700 | $128.7K | 0.00% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 58,259 | $129.9K | 0.02% | 00.0% | Unchanged |
| Barclays PLC | 67,548 | $150.6K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 70,600 | $157.4K | 0.00% | −24,000−25.4% | Reduced |
| Dimensional Fund Advisors LP | 85,853 | $191.5K | 0.00% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 130,000 | $289.9K | 0.10% | 00.0% | Unchanged |
| Tang Capital Management LLC | 144,520 | $322.3K | 0.03% | −323,402−69.1% | Reduced |
| Macquarie Group Ltd | 150,000 | $335.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 174,707 | $389.7K | 0.00% | 00.0% | Unchanged |
| Hudson Bay Capital Management LP | 203,800 | $454.5K | 0.00% | +203,800 | New |
| Citadel Advisors LLC | 245,476 | $547.4K | 0.00% | −130,374−34.7% | Reduced |
| Cardiff Park Advisors, LLC | 262,000 | $584.3K | 0.06% | +262,000 | New |
| BML Capital Management, LLC | 306,465 | $683.4K | 0.46% | 00.0% | Unchanged |
| Acuitas Investments, LLC | 321,657 | $717.3K | 0.36% | −51,142−13.7% | Reduced |
| Federated Hermes, Inc. | 327,405 | $730.1K | 0.00% | −442−0.1% | Reduced |
| Schonfeld Strategic Advisors LLC | 393,240 | $876.9K | 0.01% | +393,240 | New |
| Renaissance Technologies LLC | 400,400 | $893.0K | 0.00% | +107,085+36.5% | Added |
| Morgan Stanley | 402,258 | $897.0K | 0.00% | +321,430+397.7% | Added |
| Assenagon Asset Management S.A. | 426,717 | $951.6K | 0.00% | +426,717 | New |
| Acadian Asset Management LLC | 488,440 | $1.09M | 0.00% | 00.0% | Unchanged |
| Long Focus Capital Management, LLC | 556,105 | $1.24M | 0.14% | 00.0% | Unchanged |
| Cable Car Capital LLC | 615,878 | $1.37M | 1.92% | 00.0% | Unchanged |
| BlackRock Inc. | 761,334 | $1.70M | 0.00% | −128,768−14.5% | Reduced |
| Vanguard Group Inc | 987,324 | $2.20M | 0.00% | +83,700+9.3% | Added |
| Millennium Management LLC | 1,134,078 | $2.53M | 0.00% | −6,311−0.6% | Reduced |
| OrbiMed Advisors LLC | 1,141,200 | $2.54M | 0.05% | −1,569,813−57.9% | Reduced |
| Affinity Asset Advisors, LLC | 1,359,037 | $3.03M | 0.49% | +1,359,037 | New |
| Logos Global Management LP | 1,925,000 | $4.29M | 0.45% | +1,925,000 | New |
| Sofinnova Investments, Inc. | 2,671,856 | $5.96M | 0.35% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −26,550−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −19,588−100.0% | Sold out |